Transgene SA (LON:0OCQ)
London · Delayed Price · Currency is GBP · Price in EUR 0.8400
-0.0040 (-0.47%)
Feb 12, 2026, 8:24 AM GMT
Transgene Market Cap
Transgene has a market cap or net worth of 200.85 million as of February 12, 2026. Its market cap has increased by 161.55% in one year.
Market Cap
200.85M
Enterprise Value
213.30M
Revenue
6.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.84
Market Cap Chart
Since March 30, 1998, Transgene's market cap has increased from 98.01M to 200.85M, an increase of 104.93%. That is a compound annual growth rate of 2.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 200.85M | -12.42% |
| Dec 31, 2025 | 229.32M | 208.97% |
| Dec 31, 2024 | 74.22M | -37.92% |
| Dec 29, 2023 | 119.56M | -18.19% |
| Dec 30, 2022 | 146.14M | -29.80% |
| Dec 31, 2021 | 208.16M | 68.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| NIOX Group | 282.52M |
| Integrated Diagnostics Holdings | 270.06M |
| Avacta Group | 260.26M |
| Tristel | 206.06M |